Global Preclinical Oncology CRO Market Growth (Status and Outlook) 2022-2028
- LP 4893689
- 100 Pages
- March 2022
- Medical Devices
The United States Preclinical Oncology CRO market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Preclinical Oncology CRO market, reaching US$ million by the year 2028. As for the Europe Preclinical Oncology CRO landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Preclinical Oncology CRO players cover Crown Bioscience, Charles River Laboratory, ICON Plc., and Eurofins Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical Oncology CRO market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Blood Cancer
Solid Tumors
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
In Vitro
In Vivo
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Crown Bioscience
Charles River Laboratory
ICON Plc.
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
Wuxi AppTec.
MI Bioresearch, Inc.
Champion Oncology, Inc.
Xentech
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preclinical Oncology CRO Market Size 2017-2028
2.1.2 Preclinical Oncology CRO Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Preclinical Oncology CRO Segment by Type
2.2.1 Blood Cancer
2.2.2 Solid Tumors
2.2.3 Other
2.3 Preclinical Oncology CRO Market Size by Type
2.3.1 Preclinical Oncology CRO Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Preclinical Oncology CRO Market Size Market Share by Type (2017-2022)
2.4 Preclinical Oncology CRO Segment by Application
2.4.1 In Vitro
2.4.2 In Vivo
2.5 Preclinical Oncology CRO Market Size by Application
2.5.1 Preclinical Oncology CRO Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Preclinical Oncology CRO Market Size Market Share by Application (2017-2022)
3 Preclinical Oncology CRO Market Size by Player
3.1 Preclinical Oncology CRO Market Size Market Share by Players
3.1.1 Global Preclinical Oncology CRO Revenue by Players (2020-2022)
3.1.2 Global Preclinical Oncology CRO Revenue Market Share by Players (2020-2022)
3.2 Global Preclinical Oncology CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Preclinical Oncology CRO by Regions
4.1 Preclinical Oncology CRO Market Size by Regions (2017-2022)
4.2 Americas Preclinical Oncology CRO Market Size Growth (2017-2022)
4.3 APAC Preclinical Oncology CRO Market Size Growth (2017-2022)
4.4 Europe Preclinical Oncology CRO Market Size Growth (2017-2022)
4.5 Middle East & Africa Preclinical Oncology CRO Market Size Growth (2017-2022)
5 Americas
5.1 Americas Preclinical Oncology CRO Market Size by Country (2017-2022)
5.2 Americas Preclinical Oncology CRO Market Size by Type (2017-2022)
5.3 Americas Preclinical Oncology CRO Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preclinical Oncology CRO Market Size by Region (2017-2022)
6.2 APAC Preclinical Oncology CRO Market Size by Type (2017-2022)
6.3 APAC Preclinical Oncology CRO Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Preclinical Oncology CRO by Country (2017-2022)
7.2 Europe Preclinical Oncology CRO Market Size by Type (2017-2022)
7.3 Europe Preclinical Oncology CRO Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preclinical Oncology CRO by Region (2017-2022)
8.2 Middle East & Africa Preclinical Oncology CRO Market Size by Type (2017-2022)
8.3 Middle East & Africa Preclinical Oncology CRO Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Preclinical Oncology CRO Market Forecast
10.1 Global Preclinical Oncology CRO Forecast by Regions (2023-2028)
10.1.1 Global Preclinical Oncology CRO Forecast by Regions (2023-2028)
10.1.2 Americas Preclinical Oncology CRO Forecast
10.1.3 APAC Preclinical Oncology CRO Forecast
10.1.4 Europe Preclinical Oncology CRO Forecast
10.1.5 Middle East & Africa Preclinical Oncology CRO Forecast
10.2 Americas Preclinical Oncology CRO Forecast by Country (2023-2028)
10.2.1 United States Preclinical Oncology CRO Market Forecast
10.2.2 Canada Preclinical Oncology CRO Market Forecast
10.2.3 Mexico Preclinical Oncology CRO Market Forecast
10.2.4 Brazil Preclinical Oncology CRO Market Forecast
10.3 APAC Preclinical Oncology CRO Forecast by Region (2023-2028)
10.3.1 China Preclinical Oncology CRO Market Forecast
10.3.2 Japan Preclinical Oncology CRO Market Forecast
10.3.3 Korea Preclinical Oncology CRO Market Forecast
10.3.4 Southeast Asia Preclinical Oncology CRO Market Forecast
10.3.5 India Preclinical Oncology CRO Market Forecast
10.3.6 Australia Preclinical Oncology CRO Market Forecast
10.4 Europe Preclinical Oncology CRO Forecast by Country (2023-2028)
10.4.1 Germany Preclinical Oncology CRO Market Forecast
10.4.2 France Preclinical Oncology CRO Market Forecast
10.4.3 UK Preclinical Oncology CRO Market Forecast
10.4.4 Italy Preclinical Oncology CRO Market Forecast
10.4.5 Russia Preclinical Oncology CRO Market Forecast
10.5 Middle East & Africa Preclinical Oncology CRO Forecast by Region (2023-2028)
10.5.1 Egypt Preclinical Oncology CRO Market Forecast
10.5.2 South Africa Preclinical Oncology CRO Market Forecast
10.5.3 Israel Preclinical Oncology CRO Market Forecast
10.5.4 Turkey Preclinical Oncology CRO Market Forecast
10.5.5 GCC Countries Preclinical Oncology CRO Market Forecast
10.6 Global Preclinical Oncology CRO Forecast by Type (2023-2028)
10.7 Global Preclinical Oncology CRO Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Information
11.1.2 Crown Bioscience Preclinical Oncology CRO Product Offered
11.1.3 Crown Bioscience Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Crown Bioscience Main Business Overview
11.1.5 Crown Bioscience Latest Developments
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Information
11.2.2 Charles River Laboratory Preclinical Oncology CRO Product Offered
11.2.3 Charles River Laboratory Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Charles River Laboratory Main Business Overview
11.2.5 Charles River Laboratory Latest Developments
11.3 ICON Plc.
11.3.1 ICON Plc. Company Information
11.3.2 ICON Plc. Preclinical Oncology CRO Product Offered
11.3.3 ICON Plc. Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 ICON Plc. Main Business Overview
11.3.5 ICON Plc. Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Preclinical Oncology CRO Product Offered
11.4.3 Eurofins Scientific Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Information
11.5.2 Taconic Biosciences Preclinical Oncology CRO Product Offered
11.5.3 Taconic Biosciences Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Taconic Biosciences Main Business Overview
11.5.5 Taconic Biosciences Latest Developments
11.6 Covance
11.6.1 Covance Company Information
11.6.2 Covance Preclinical Oncology CRO Product Offered
11.6.3 Covance Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Covance Main Business Overview
11.6.5 Covance Latest Developments
11.7 EVOTEC
11.7.1 EVOTEC Company Information
11.7.2 EVOTEC Preclinical Oncology CRO Product Offered
11.7.3 EVOTEC Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 EVOTEC Main Business Overview
11.7.5 EVOTEC Latest Developments
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Information
11.8.2 The Jackson Laboratory Preclinical Oncology CRO Product Offered
11.8.3 The Jackson Laboratory Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 The Jackson Laboratory Main Business Overview
11.8.5 The Jackson Laboratory Latest Developments
11.9 Wuxi AppTec.
11.9.1 Wuxi AppTec. Company Information
11.9.2 Wuxi AppTec. Preclinical Oncology CRO Product Offered
11.9.3 Wuxi AppTec. Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Wuxi AppTec. Main Business Overview
11.9.5 Wuxi AppTec. Latest Developments
11.10 MI Bioresearch, Inc.
11.10.1 MI Bioresearch, Inc. Company Information
11.10.2 MI Bioresearch, Inc. Preclinical Oncology CRO Product Offered
11.10.3 MI Bioresearch, Inc. Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 MI Bioresearch, Inc. Main Business Overview
11.10.5 MI Bioresearch, Inc. Latest Developments
11.11 Champion Oncology, Inc.
11.11.1 Champion Oncology, Inc. Company Information
11.11.2 Champion Oncology, Inc. Preclinical Oncology CRO Product Offered
11.11.3 Champion Oncology, Inc. Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Champion Oncology, Inc. Main Business Overview
11.11.5 Champion Oncology, Inc. Latest Developments
11.12 Xentech
11.12.1 Xentech Company Information
11.12.2 Xentech Preclinical Oncology CRO Product Offered
11.12.3 Xentech Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Xentech Main Business Overview
11.12.5 Xentech Latest Developments
12 Research Findings and Conclusion
Table 1. Preclinical Oncology CRO Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Blood Cancer
Table 3. Major Players of Solid Tumors
Table 4. Major Players of Other
Table 5. Preclinical Oncology CRO Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Preclinical Oncology CRO Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Preclinical Oncology CRO Market Size Market Share by Type (2017-2022)
Table 8. Preclinical Oncology CRO Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Preclinical Oncology CRO Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Preclinical Oncology CRO Market Size Market Share by Application (2017-2022)
Table 11. Global Preclinical Oncology CRO Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Preclinical Oncology CRO Revenue Market Share by Player (2020-2022)
Table 13. Preclinical Oncology CRO Key Players Head office and Products Offered
Table 14. Preclinical Oncology CRO Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Preclinical Oncology CRO Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Preclinical Oncology CRO Market Size Market Share by Regions (2017-2022)
Table 19. Americas Preclinical Oncology CRO Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Preclinical Oncology CRO Market Size Market Share by Country (2017-2022)
Table 21. Americas Preclinical Oncology CRO Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Preclinical Oncology CRO Market Size Market Share by Type (2017-2022)
Table 23. Americas Preclinical Oncology CRO Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Preclinical Oncology CRO Market Size Market Share by Application (2017-2022)
Table 25. APAC Preclinical Oncology CRO Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Preclinical Oncology CRO Market Size Market Share by Region (2017-2022)
Table 27. APAC Preclinical Oncology CRO Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Preclinical Oncology CRO Market Size Market Share by Type (2017-2022)
Table 29. APAC Preclinical Oncology CRO Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Preclinical Oncology CRO Market Size Market Share by Application (2017-2022)
Table 31. Europe Preclinical Oncology CRO Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Preclinical Oncology CRO Market Size Market Share by Country (2017-2022)
Table 33. Europe Preclinical Oncology CRO Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Preclinical Oncology CRO Market Size Market Share by Type (2017-2022)
Table 35. Europe Preclinical Oncology CRO Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Preclinical Oncology CRO Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Preclinical Oncology CRO Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Preclinical Oncology CRO Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Preclinical Oncology CRO Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Preclinical Oncology CRO
Table 44. Key Market Challenges & Risks of Preclinical Oncology CRO
Table 45. Key Industry Trends of Preclinical Oncology CRO
Table 46. Global Preclinical Oncology CRO Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Preclinical Oncology CRO Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Preclinical Oncology CRO Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Preclinical Oncology CRO Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Preclinical Oncology CRO Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Preclinical Oncology CRO Market Size Market Share Forecast by Application (2023-2028)
Table 52. Crown Bioscience Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 53. Crown Bioscience Preclinical Oncology CRO Product Offered
Table 54. Crown Bioscience Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Crown Bioscience Main Business
Table 56. Crown Bioscience Latest Developments
Table 57. Charles River Laboratory Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 58. Charles River Laboratory Preclinical Oncology CRO Product Offered
Table 59. Charles River Laboratory Main Business
Table 60. Charles River Laboratory Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Charles River Laboratory Latest Developments
Table 62. ICON Plc. Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 63. ICON Plc. Preclinical Oncology CRO Product Offered
Table 64. ICON Plc. Main Business
Table 65. ICON Plc. Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. ICON Plc. Latest Developments
Table 67. Eurofins Scientific Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 68. Eurofins Scientific Preclinical Oncology CRO Product Offered
Table 69. Eurofins Scientific Main Business
Table 70. Eurofins Scientific Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Eurofins Scientific Latest Developments
Table 72. Taconic Biosciences Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 73. Taconic Biosciences Preclinical Oncology CRO Product Offered
Table 74. Taconic Biosciences Main Business
Table 75. Taconic Biosciences Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Taconic Biosciences Latest Developments
Table 77. Covance Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 78. Covance Preclinical Oncology CRO Product Offered
Table 79. Covance Main Business
Table 80. Covance Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Covance Latest Developments
Table 82. EVOTEC Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 83. EVOTEC Preclinical Oncology CRO Product Offered
Table 84. EVOTEC Main Business
Table 85. EVOTEC Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. EVOTEC Latest Developments
Table 87. The Jackson Laboratory Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 88. The Jackson Laboratory Preclinical Oncology CRO Product Offered
Table 89. The Jackson Laboratory Main Business
Table 90. The Jackson Laboratory Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. The Jackson Laboratory Latest Developments
Table 92. Wuxi AppTec. Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 93. Wuxi AppTec. Preclinical Oncology CRO Product Offered
Table 94. Wuxi AppTec. Main Business
Table 95. Wuxi AppTec. Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Wuxi AppTec. Latest Developments
Table 97. MI Bioresearch, Inc. Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 98. MI Bioresearch, Inc. Preclinical Oncology CRO Product Offered
Table 99. MI Bioresearch, Inc. Main Business
Table 100. MI Bioresearch, Inc. Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. MI Bioresearch, Inc. Latest Developments
Table 102. Champion Oncology, Inc. Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 103. Champion Oncology, Inc. Preclinical Oncology CRO Product Offered
Table 104. Champion Oncology, Inc. Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Champion Oncology, Inc. Main Business
Table 106. Champion Oncology, Inc. Latest Developments
Table 107. Xentech Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 108. Xentech Preclinical Oncology CRO Product Offered
Table 109. Xentech Main Business
Table 110. Xentech Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Xentech Latest Developments
List of Figures
Figure 1. Preclinical Oncology CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Preclinical Oncology CRO Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Preclinical Oncology CRO Market Size Market Share by Type in 2021
Figure 7. Preclinical Oncology CRO in In Vitro
Figure 8. Global Preclinical Oncology CRO Market: In Vitro (2017-2022) & ($ Millions)
Figure 9. Preclinical Oncology CRO in In Vivo
Figure 10. Global Preclinical Oncology CRO Market: In Vivo (2017-2022) & ($ Millions)
Figure 11. Global Preclinical Oncology CRO Market Size Market Share by Application in 2021
Figure 12. Global Preclinical Oncology CRO Revenue Market Share by Player in 2021
Figure 13. Global Preclinical Oncology CRO Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Preclinical Oncology CRO Market Size 2017-2022 ($ Millions)
Figure 15. APAC Preclinical Oncology CRO Market Size 2017-2022 ($ Millions)
Figure 16. Europe Preclinical Oncology CRO Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Preclinical Oncology CRO Market Size 2017-2022 ($ Millions)
Figure 18. Americas Preclinical Oncology CRO Value Market Share by Country in 2021
Figure 19. Americas Preclinical Oncology CRO Consumption Market Share by Type in 2021
Figure 20. Americas Preclinical Oncology CRO Market Size Market Share by Application in 2021
Figure 21. United States Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Preclinical Oncology CRO Market Size Market Share by Region in 2021
Figure 26. APAC Preclinical Oncology CRO Market Size Market Share by Application in 2021
Figure 27. China Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Preclinical Oncology CRO Market Size Market Share by Country in 2021
Figure 34. Europe Preclinical Oncology CRO Market Size Market Share by Type in 2021
Figure 35. Europe Preclinical Oncology CRO Market Size Market Share by Application in 2021
Figure 36. Germany Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Application in 2021
Figure 44. Egypt Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Preclinical Oncology CRO Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 50. APAC Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 51. Europe Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 53. United States Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 54. Canada Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 57. China Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 58. Japan Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 59. Korea Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 61. India Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 62. Australia Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 63. Germany Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 64. France Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 65. UK Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 66. Italy Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 67. Russia Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 68. Spain Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 71. Israel Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Preclinical Oncology CRO Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
